Introduction
Materials and methods
Data basis
Endpoints
ICD-10 | Description | Time period |
---|---|---|
N45 | Orchitis and epididymitis | IA + RA 90 days |
N49.2 | Inflammatory disorders of scrotum | RA 90 days |
N50.0 | Atrophy of testis | RA 90 days |
N50.1 | Vascular disorders of male genital organs | RA 90 days |
T81.0a | Hemorrhage and hematoma as a complication of a procedure, not elsewhere classified | IA + RA 7 days |
A41 | Sepsis, unspecified | RA 14 days |
K65 | Peritonitis | RA 14 days |
T81.4 | Infection following a procedure, not elsewhere classified | IA + RA 14 days |
I26 | Pulmonary embolism | IA + RA 30 days |
I80.1 | Thrombosis, phlebitis and thrombophlebitis of femoral vein | IA + RA 90 days |
I80.2 | Thrombosis, phlebitis and thrombophlebitis of other deep vessels of lower extremities | IA + RA 90 days |
I80.3 | Thrombosis, phlebitis and thrombophlebitis of other extremities, unspecified | IA + RA 90 days |
I82.2 | Embolism and thrombosis of vena cava | IA + RA 90 days |
K56 | Paralytic ileus and intestinal obstruction, no hernia | RA 90 days |
K63.1 | Perforation of intestine (nontraumatic) | IA + RA 90 days |
K66.0 | Peritoneal adhesions | RA 90 days |
K66.1 | Hemoperitoneum | RA 90 days |
K91.3 | Postprocedural intestinal obstruction | IA + RA 90 days |
K91.83 | Anastomosis and suture insufficiency following surgery elsewhere in the digestive tract | IA + RA 90 days |
K91.88 | Other disorders of the digestive system following medical measures, not elsewhere classified | IA + RA 90 days |
K91.9 | Disorder of the digestive system following medical measures, unspecified | IA + RA 90 days |
T81.1 | Shock during or resulting from a procedure, not elsewhere classified | IA + RA 90 days |
T81.2 | Accidental puncture or laceration during a procedure, not elsewhere classified | IA + RA 90 days |
T81.3 | Disruption of surgical wound, not elsewhere classified | IA + RA 90 days |
T81.5 | Foreign body accidentally left in body cavity or operation wound following a procedure | IA + RA 90 days |
T81.6 | Acute reaction to foreign substance accidentally left during a procedure | IA + RA 90 days |
T81.7 | Vascular complications following a procedure, not elsewhere classified | IA + RA 90 days |
T81.8 | Other complications of procedures, not elsewhere classified | IA + RA 90 days |
T81.9 | Unspecified complication of procedure | IA + RA 90 days |
OPS | Description | Time period |
---|---|---|
(a) | ||
5-388.3 | Suture of blood vessels: Aorta | 0–90 days |
5-388.5 | Suture of blood vessels: Abdominal and pelvic | 0–90 days |
5-388.6 | Suture of blood vessels: Visceral arteries | 0–90 days |
5-388.7 | Suture of blood vessels: Femoral arteries | 0–90 days |
5-388.9 | Suture of blood vessels: Deep veins | 0–90 days |
5-388.a | Suture of blood vessels: Superficial veins | 0–90 days |
5-467.0 | Other reconstruction of intestines: Suture (following injury) | 0–90 days |
5-467.1 | Other reconstruction of intestines: Repair of intestinal fistula, open surgery | 1–90 days |
5-467.5 | Other reconstruction of intestines: Revision following anastomosis | RA 90 days |
5-469.0 | Other operation of intestines: Decompression | RA 90 days |
5-469.1 | Other operation of intestines: Adhesiolysis | RA 90 days |
5-469.2 | Other operation of intestines: Adhesiolysis | RA 90 days |
5-469.e | Other operation of intestines: Injection | RA 90 days |
5-530a | Inguinal hernia repair | 1–90 days |
5-540.0 | Incision of abdominal wall: Exploration | RA 90 days |
5-540.1 | Incision of abdominal wall: Extraperitoneal drainage | RA 90 days |
5-540.2 | Incision of abdominal wall: Removal of a foreign body | RA 90 days |
5-541.0 | Laparotomy and opening of retroperitoneum: Explorative laparotomy | 1–90 days |
5-541.1 | Laparotomy and opening of retroperitoneum: Laparotomy with drainage | 1–90 days |
5-541.2 | Laparotomy and opening of retroperitoneum: Relaparotomy | RA 90 days |
5-541.3 | Laparotomy and opening of retroperitoneum: Second-look laparotomy (programmed relaparotomy) | RA 90 days |
5-541.4 | Laparotomy and opening of retroperitoneum: Placement of temporary abdominal wall closure | RA 90 days |
5-545.0 | Closure of abdominal wall and peritoneum: Secondary closure of abdominal wall (for postoperative wound dehiscence) | 1–90 days |
5-549.0 | Other abdominal operations: Removal of a foreign body from abdominal cavity | 1–90 days |
5-549.5 | Other abdominal operations: Laparoscopy with drainage | 1–90 days |
5-590.2 | Incision and excision of retroperitoneal tissue: Drainage, retroperitoneal | RA 90 days |
5-590.3 | Incision and excision of retroperitoneal tissue: Drainage, pelvic | RA 90 days |
5-892.1[b,c] | Other incision of the skin and subcutaneous tissues: Drainage ((abdominal/inguinal/genital regions) | 1–90 days |
5-892.3[b,c] | Other incision of the skin and subcutaneous tissues: Implantation of a drug delivery system (abdominal/inguinal/genital regions) | 1–90 days |
5-895.0[b,c] | Radical and extensive excision of diseased tissue from the skin and subcutaneous tissues: Without primary wound closure ((abdominal/inguinal/genital regions) | 1–90 days |
5-895.1[b,c] | Radical and extensive excision of diseased tissue from the skin and subcutaneous tissues: Without primary wound closure, under histographic control (abdominal/inguinal/genital regions) | 1–90 days |
5-895.2[b,c] | Radical and extensive excision of diseased tissue from the skin and subcutaneous tissues: With primary wound closure | 1–90 days |
5-895.3[b,c] | Radical and extensive excision of diseased tissue from the skin and subcutaneous tissues: With primary wound closure, under histographic control (abdominal/inguinal/genital regions) | 1–90 days |
5-916.a0b | Temporary soft tissue coverage: Placement or replacement of a system for vacuum sealing of the skin and subcutaneous tissues | 2–90 days |
5-916.a3b | Temporary soft tissue coverage: Placement or replacement of a system for vacuum sealing of open abdomen | 2–90 days |
5-983 | Reoperation | 1–90 days |
8-153 | Therapeutic percutaneous puncture of abdominal cavity | 1–90 days |
8-159.x | Other therapeutic percutaneous puncture: Unspecified | 1–90 days |
8-176 | Therapeutic irrigation of the abdominal cavity with indwelling drain and temporary abdominal wall closure | 1–90 days |
8-190b | Special bandaging techniques | 2–90 days |
5-578.0 | Other plastic reconstruction of urinary bladder: Suture (following injury) | 0–30 days |
5-622 | Orchidectomy | 1–90 days |
5-639.1 | Other operations of spermatic cord, epididymis and vas deferens: Incision of spermatic cord | RA 90 days |
5-639.2 | Other operations of spermatic cord, epididymis and vas deferens: Adhesiolysis of spermatic cord | RA 90 days |
5-639.x | Other operations of spermatic cord, epididymis and vas deferens: Unspecified | RA 90 days |
8-132.3 | Manipulations of urinary bladder: Irrigation, continuous | RA 30 days |
8-800 | Transfusion of whole blood, erythrocyte concentrate and thrombocyte concentrate | 0–7 days |
5-896.1[b,c] | Surgical wound toilet (wound debridement) with removal of diseased tissue from the skin and subcutaneous tissues: Extensive ((abdominal/inguinal/genital regions) | 1–14 days |
5-896.2[b,c] | Surgical wound toilet (wound debridement) with removal of diseased tissue from the skin and subcutaneous tissues: Extensive with implantation of a drug delivery system (abdominal/inguinal/genital regions) | 1–14 days |
8-771 | Cardiac or cardiopulmonary resuscitation | 0–30 days |
8-772 | Operative resuscitation | 0–30 days |
8-779 | Other resuscitation measures | 0–30 days |
Statistical analysis
Results
Total | I | II | III | IV | V | |
---|---|---|---|---|---|---|
Caseloads, age and gender | ||||||
Annual caseload | – | 1–50 | 51–75 | 76–100 | 101–125 | ≥ 126 |
AOK cases (N) | 133.449 | 4.586 | 12.105 | 17.985 | 20.776 | 77.997 |
Age (median; IQR) | 59 (47–73) | 60 (49–74) | 61 (48–74) | 60 (48–74) | 60 (48–73) | 59 (47–73) |
Gender (female, %) | 11.33 | 11.16 | 10.04 | 11.15 | 11.20 | 11.61 |
Risk factors and surgical technique (%) | ||||||
Recurrence present on admission | 11.66 | 12.10 | 11.31 | 12.12 | 11.77 | 11.55 |
Incarceration | 9.42 | 10.64 | 11.93 | 11.10 | 9.86 | 8.45 |
Gangrene | 0.44 | 0.48 | 0.45 | 0.50 | 0.46 | 0.42 |
Emergency | 4.08 | 4.62 | 5.15 | 4.96 | 4.36 | 3.60 |
Bilateral procedure | 15.61 | 9.97 | 11.55 | 12.64 | 14.56 | 17.53 |
Intestinal procedure | 0.35 | 0.44 | 0.35 | 0.42 | 0.32 | 0.34 |
Simultaneous repair of umbilical hernia | 5.35 | 3.99 | 4.38 | 4.73 | 4.93 | 5.84 |
Simultaneous repair of femoral hernia | 0.38 | 0.44 | 0.36 | 0.36 | 0.37 | 0.39 |
Simultaneous repair of incisional hernia | 0.32 | 0.26 | 0.28 | 0.33 | 0.32 | 0.32 |
Outpatient repair | 11.21 | 13.06 | 12.43 | 11.08 | 11.79 | 10.79 |
Open suture procedure | 6.20 | 10.60 | 7.45 | 7.09 | 5.37 | 5.76 |
Open mesh procedure | 37.92 | 49.30 | 43.89 | 41.03 | 40.85 | 34.82 |
Minimally invasive mesh procedure | 55.89 | 40.10 | 48.66 | 51.88 | 53.78 | 59.42 |
Preoperative medication (%) | ||||||
Immunosuppressants | 0.74 | 0.76 | 0.70 | 0.71 | 0.73 | 0.75 |
Systemic glucocorticoids | 1.70 | 1.92 | 1.76 | 1.85 | 1.55 | 1.69 |
Antithrombotics | 13.10 | 14.17 | 14.46 | 13.88 | 13.72 | 12.48 |
Treatment for chronic inflammatory bowel disease | 0.32 | 0.31 | 0.37 | 0.36 | 0.34 | 0.31 |
BMI and Elixhauser comorbiditiesa (%) | ||||||
Obesity grade, unspecified | 0.30 | 0.44 | 0.23 | 0.37 | 0.26 | 0.30 |
Grade I obesity | 2.79 | 3.47 | 2.73 | 2.66 | 2.81 | 2.79 |
Grade II obesity | 0.93 | 1.02 | 0.98 | 0.86 | 1.04 | 0.91 |
Grade III obesity | 0.36 | 0.57 | 0.40 | 0.36 | 0.34 | 0.35 |
Hypertension, no complications | 31.34 | 34.89 | 34.69 | 33.37 | 32.36 | 29.87 |
Cardiac arrhythmia | 8.02 | 9.16 | 9.24 | 9.13 | 8.39 | 7.41 |
Diabetes, no complications | 7.22 | 8.70 | 7.73 | 8.01 | 7.47 | 6.81 |
Chronic lung disease | 5.38 | 6.13 | 6.39 | 5.67 | 5.35 | 5.12 |
Hypothyroidism | 4.32 | 4.21 | 4.22 | 4.24 | 4.24 | 4.39 |
Congestive heart disease | 3.37 | 4.27 | 4.22 | 3.96 | 3.71 | 2.95 |
Real failure/insufficiency | 3.13 | 3.92 | 3.88 | 3.46 | 3.46 | 2.80 |
Peripheral occlusive vascular disease | 2.30 | 2.94 | 2.45 | 2.67 | 2.37 | 2.13 |
Disorders of the water and electrolyte balance as well as of the acid–base balance | 1.97 | 2.25 | 2.19 | 2.16 | 1.94 | 1.88 |
Other neurologic diseases | 1.92 | 2.35 | 2.00 | 2.17 | 2.04 | 1.78 |
Heart valve disease | 1.82 | 2.18 | 2.08 | 2.20 | 1.85 | 1.67 |
Coagulopathy | 1.68 | 1.92 | 1.96 | 1.88 | 1.75 | 1.56 |
Depression | 1.66 | 2.20 | 1.86 | 1.83 | 1.70 | 1.54 |
Hypertension, with complications | 1.55 | 1.92 | 1.74 | 1.79 | 1.74 | 1.38 |
Endpoints
Total (%) | I (%) | II (%) | III (%) | IV (%) | V (%) | P | |
---|---|---|---|---|---|---|---|
Surgical complications (90 days) | 4.22 | 4.49 | 4.61 | 4.55 | 4.10 | 4.11 | 0.001 |
Recurrence (91–365 days) | 0.95 | 1.38 | 1.11 | 1.00 | 0.84 | 0.93 | 0.003 |
Pain management (365 days) | 2.87 | 3.31 | 3.03 | 2.84 | 2.94 | 2.80 | 0.043 |
Mortality (30 days) | 0.28 | 0.31 | 0.35 | 0.37 | 0.27 | 0.25 | 0.010 |
Influence of the caseload volume
Influencing factors | Surgical complications (90 days) | Recurrence procedure (91–365 days) | Pain management (365 days) | Mortality (30 days) |
---|---|---|---|---|
Volume categories (caseload annual) | ||||
I (1–50) | 0.94 (0.79–1.13) | 1.53 (1.17–1.98) | 1.09 (0.93–1.28) | 1.00 (0.55–1.82) |
II (51–75) | 1.01 (0.90–1.14) | 1.24 (1.01–1.55) | 1.03 (0.91–1.16) | 1.06 (0.71–1.58) |
III (76–100) | 1.01 (0.91–1.12) | 1.10 (0.91–1.34) | 0.97 (0.87–1.07) | 1.11 (0.82–1.50) |
IV (101–125) | 0.94 (0.85–1.05) | 0.93 (0.77–1.12) | 1.02 (0.93–1.12) | 0.83 (0.59–1.17) |
V (≥ 126) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
Age in years | ||||
18–44 | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
45–55 | 1.20 (1.07–1.35) | – | 1.93 (1.69–2.21) | – |
56–64 | 1.31 (1.16–1.49) | – | 2.05 (1.79–2.35) | – |
65–75 | 1.51 (1.35–1.69) | – | 1.96 (1.71–2.25) | 4.98 (2.95–8.41) |
76–102 | 1.81 (1.60–2.04) | 0.78 (0.66–0.92) | 2.46 (2.14–2.83) | 13.7 (8.47–22.16) |
Risk factors and surgical technique | ||||
Gender (female) | – | – | 1.54 (1.40–1.68) | – |
Recurrence present on admission | 1.32 (1.22–1.44) | 1.36 (1.17–1.59) | 1.20 (1.10–1.32) | – |
Incarceration | 1.71 (1.58–1.85) | – | – | 2.40 (1.73–3.33) |
Gangrene | 2.17 (1.62–2.89) | – | – | 2.77 (1.46–5.25) |
Emergency | – | – | – | 1.86 (1.32–2.63) |
Bilateral operation | 1.23 (1.12–1.35) | 1.58 (1.38–1.81) | 1.12 (1.02–1.24) | – |
Intestinal procedure | 3.77 (2.78–5.12) | – | – | 1.97 (1.17–3.30) |
Umbilical hernia repair | – | – | – | 2.03 (1.16–3.55) |
Femoral hernia repair | 1.51 (1.05–2.17) | 2.12 (1.12 – 4.00) | – | – |
Incisional hernia repair | 1.78 (1.22–2.58) | – | – | – |
Preoperative therapy with systemic glucocorticoids | 1.29 (1.09–1.52) | – | 2.04 (1.70–2.46) | 2.15 (1.35–3.41) |
Preoperative antithrombotic therapy | 1.11 (1.01–1.21) | – | 1.16 (1.06–1.28) | – |
Day care surgical repair | – | – | – | 0.09 (0.01–0.62) |
Open mesh procedure | 0.63 (0.51–0.78) | 0.42 (0.34–0.52) | – | 0.52 (0.39–0.70) |
Minimally invasive mesh procedure | 0.48 (0.38–0.60) | 0.51 (0.41–0.62) | 0.91 (0.84–0.98) | 0.22 (0.15–0.33) |
BMI and Elixhauser comorbidities | ||||
Grade II obesity | 1.63 (1.30–2.06) | – | 1.70 (1.32–2.20) | – |
Grade III obesity | 3.25 (2.41–4.40) | – | 2.49 (1.72–3.60) | – |
Grade obesity unspecified | – | – | 1.65 (1.06–2.55) | – |
Alcohol abuse | – | – | 2.05 (1.55–2.73) | – |
Cardiac arrhythmia | 1.36 (1.23–1.50) | – | – | 1.63 (1.25–2.12) |
Congestive heart disease | 1.17 (1.03–1.32) | – | 1.34 (1.16–1.54) | 2.41 (1.79–3.24) |
Coagulopathy | 2.51 (2.20–2.86) | – | – | 2.27 (1.62–3.17) |
Chronic lung disease | – | – | 1.51 (1.35–1.70) | – |
Deficiency anemia | 1.70 (1.17–2.47) | – | – | – |
Depression | 1.43 (1.20–1.71) | – | 1.39 (1.13–1.71) | – |
Diabetes, with complications | – | – | 1.39 (1.04–1.86) | – |
Diabetes, no complications | 1.13 (1.03–1.24) | – | 1.21 (1.09–1.35) | – |
Drug abuse | – | 3.43 (1.61–7.28) | 2.40 (1.40–4.13) | – |
Disorders of the water and electrolyte balance as well as of the acid–base balance | 3.04 (2.65–3.48) | 1.65 (1.17–2.32) | 1.26 (1.05–1.51) | 3.73 (2.82–4.95) |
Hypertension, with complications | 0.76 (0.61–0.94) | – | – | 0.38 (0.23–0.63) |
Hypertension, no complications | – | – | 1.18 (1.09–1.28) | 0.59 (0.47–0.75) |
Liver disease | 2.33 (1.89–2.86) | – | – | 4.86 (2.99–7.91) |
Other neurologic diseases | – | – | – | 1.62 (1.05–2.52) |
Paralysis | – | – | 1.49 (1.09–2.03) | – |
Pulmonary heart disease and diseases of the pulmonary circulation | 1.61 (1.18–2.19) | – | – | 1.81 (1.04–3.14) |
Peripheral occlusive vascular disease | – | – | 1.41 (1.19–1.67) | – |
Real failure/insufficiency | 1.26 (1.12–1.43) | – | – | 1.52 (1.14–2.04) |
Rheumatoid disease | – | – | 2.02 (1.52–2.68) | – |
Heart valve disease | 1.26 (1.07–1.49) | – | – | – |
Weight loss | 1.94 (1.34–2.82) | – | – | 2.40 (1.29–4.46) |
Logistic model | Mean VIF | Maximal VIF of a single predictor |
---|---|---|
Surgical complications | 1.37 | 3.33 |
Recurrence procedure | 1.23 | 1.75 |
Pain management | 1.23 | 2.06 |
Mortality | 1.33 | 2.16 |